Closing the Barn Door After the Sheep Are Gone? Zhaoyan Pharmaceutical Plummets and Hastily Reduces Shareholding Reduction Ratio

Question: Can the reduction in the share reduction ratio reverse market panic?

On March 17, Zhaoyan New Drug (603127.SH) quickly issued an announcement to adjust its share reduction plan after the previous disclosure of a shareholder reduction plan triggered a limit-down. The adjustment involved lowering the share reduction ratio and optimizing the reduction method. This reversal operation attracted widespread market attention, with investors speculating on its impact on the stock price tomorrow. Market interpretations vary significantly.

Reviewing the event, last night Zhaoyan New Drug announced that shareholders Gu Xiaolei and Gu Meifang planned to reduce their holdings by no more than 4.1026% of the company’s total shares. The news caused market panic today. By the close, Zhaoyan New Drug hit the limit-down, closing at 29.32 yuan, with a total trading volume of 855 million yuan. The amount of sell orders at the limit-down was 24.94 million yuan, indicating a clear sign of capital fleeing.

Just as market sentiment had not yet stabilized, Zhaoyan New Drug issued another announcement today to correct the reduction plan: shareholders Gu Xiaolei and Gu Meifang will lower their combined reduction ratio from no more than 4.1026% to 3.00%, a decrease of about 1.1 percentage points. Meanwhile, the reduction method will shift from a single centralized bidding to a combination of centralized bidding and block trades.

There are two main interpretations of this adjustment. The optimistic view believes that lowering the reduction ratio and adding block trades send positive signals from shareholders, reducing direct selling pressure on the secondary market and reflecting shareholders’ confidence in the company’s long-term value. This could help ease market panic and potentially stabilize and recover the stock price tomorrow. The cautious view suggests that although the adjustment is a relief, the fundamental nature of the reduction has not changed. A 3.00% reduction still constitutes a large-scale sell-off. Although the company’s fundamentals have not significantly deteriorated recently, the stock price has been declining steadily, and the emotional impact of yesterday’s limit-down remains. In the short term, market sentiment is unlikely to quickly dissipate, and the stock may continue to fluctuate. Whether it can stabilize depends on the strength of capital support.

Whether this adjustment can reverse market sentiment and stabilize the stock price remains a key focus for tomorrow’s market.

Risk reminder: This article is for informational purposes only and does not constitute any investment advice. Stock price movements are influenced by multiple factors such as market sentiment and capital flows. Investors should make rational decisions and exercise caution.